Patent · US Active

Proteostasis regulators

US10532996B2 · kind B2 · utility

0Cited by

28References

5Claims

0Family size

Assignee

Proteostasis Therapeutics, Inc. · US

Inventors

Megan Foley · Somerville, US
Bradley Tait · Killingworth, US
Matthew Cullen · Los Angeles, US

Key dates

Filing date	Jan 10, 2017
Grant date	Jan 14, 2020
Priority date	—
Expiry date	Jan 10, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention is directed to compounds having the Formulae (Ia-Ie), (II), (IIIa-IIId), (IVa-IVc), (Va-Vb), (VIa-VIe), (VII), (VIIIa-VIIIc), and (IX), pharmaceutically acceptable salts, prodrugs and solvates thereof, compositions of any of thereof and methods for the treatment of a condition associated with a dysfunction in proteostasis comprising an effective amount of these compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.